GROSSMAN ADAM S (President and CEO) reported 2 transactions at ADMA BIOLOGICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/10/2026ACC: 0001140361-26-008904
DirectorOfficer· President and CEO
Since Feb 2026
-85.95K
Net shares
Net seller
$1.32M
Total sold
0
Open market trades
0B · 0S
2
Total transactions
85.95K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−56.44K
Price / share
$15.39
Trade value
$868.58K
% of position
2.6%
3/6/2026
2.20M→2.15M
Common Stock
Direct
Shares
−29.51K
Price / share
$15.39
Trade value
$454.21K
% of position
1.4%
3/7/2026
2.15M→2.12M
Total
Net shares
−85.95K
Net value
-$1.32M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/6/2026 | F · Tax Withholding | −56.44K | $15.39 | $868.58K | 2.6% | 2.20M | 2.15M |
| Common Stock Direct | 3/7/2026 | F · Tax Withholding | −29.51K | $15.39 | $454.21K | 1.4% | 2.15M | 2.12M |
| Total | −85.95K | -$1.32M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1.14M
Common Stock
IndirectShares owned580.96K
Total
1.72M indirect1.72M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.14M | Indirect |
| Common Stock | 580.96K | Indirect |
| Total | 1.72M | 1.72M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported